TRANSFORMATIVE EXOSOME THERAPEUTICS: Utilising our DeliverEXTM platform, we are engineering exosomes to deliver protein and nucleic acid-based therapeutics to treat life-threatening rare diseases. At Evox Therapeutics we are harnessing and engineering the natural delivery capabilities of exosomes to develop an entirely novel class of biotherapeutics. Naturally Inspired. Engineered to Deliver.
Redmile Group, OrbiMed, Invus, Oxford Sciences Innovation (OSI), GV (formerly Google Ventures) & Cowen Healthcare Investments